441 related articles for article (PubMed ID: 9533442)
1. Regulation of T cell autoreactivity to MHC class II by controlling CD80 (B7-1) expression on B cells.
Hasegawa A; Ueno Y; Yamashita M; Nakayama T; Tada T
Int Immunol; 1998 Feb; 10(2):147-58. PubMed ID: 9533442
[TBL] [Abstract][Full Text] [Related]
2. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice.
Zhou T; Bluethmann H; Eldridge J; Brockhaus M; Berry K; Mountz JD
J Immunol; 1991 Jul; 147(2):466-74. PubMed ID: 1830064
[TBL] [Abstract][Full Text] [Related]
3. A novel form of self tolerance dictated in the thymus of transgenic mice with autoreactive TCR alpha and beta chain genes.
Kubo S; Nakayama T; Furutani-Seiki M; Kishimoto H; Hashimoto K; Bae MJ; Yokochi T; Takeda N; Aizawa S; Asano Y
Int Immunol; 1994 Apr; 6(4):593-602. PubMed ID: 8018599
[TBL] [Abstract][Full Text] [Related]
4. Self-specific MHC class II-restricted CD4-CD8- T cells that escape deletion and lack regulatory activity.
Viret C; Janeway CA
J Immunol; 2003 Jan; 170(1):201-9. PubMed ID: 12496401
[TBL] [Abstract][Full Text] [Related]
5. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
6. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
Nieland JD; Kruisbeek AM
Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
[TBL] [Abstract][Full Text] [Related]
7. The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model.
Girgis L; Davis MM; Fazekas de St Groth B
J Exp Med; 1999 Jan; 189(2):265-78. PubMed ID: 9892609
[TBL] [Abstract][Full Text] [Related]
8. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
9. A minimal level of MHC class II expression is sufficient to abrogate autoreactivity.
de Bont ES; Reilly CR; Lo D; Glimcher LH; Laufer TM
Int Immunol; 1999 Aug; 11(8):1295-306. PubMed ID: 10421787
[TBL] [Abstract][Full Text] [Related]
10. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
11. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.
Park JJ; Omiya R; Matsumura Y; Sakoda Y; Kuramasu A; Augustine MM; Yao S; Tsushima F; Narazaki H; Anand S; Liu Y; Strome SE; Chen L; Tamada K
Blood; 2010 Aug; 116(8):1291-8. PubMed ID: 20472828
[TBL] [Abstract][Full Text] [Related]
12. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
13. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
15. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
Clatza A; Bonifaz LC; Vignali DA; Moreno J
J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
[TBL] [Abstract][Full Text] [Related]
16. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance.
Yan J; Mamula MJ
J Immunol; 2002 Apr; 168(7):3188-94. PubMed ID: 11907071
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
[TBL] [Abstract][Full Text] [Related]
18. Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells.
Rigby SM; Rouse T; Field EH
Blood; 2003 Mar; 101(5):2024-32. PubMed ID: 12406908
[TBL] [Abstract][Full Text] [Related]
19. Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells.
Gao JX; Zhang H; Bai XF; Wen J; Zheng X; Liu J; Zheng P; Liu Y
J Exp Med; 2002 Apr; 195(8):959-71. PubMed ID: 11956287
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.
Rider BJ; Fraga E; Yu Q; Singh B
Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
